Dr. Viralkumar Bhanderi
Claim this profileFlorida Cancer Specialists
Area of expertise
Cancer
Viralkumar Bhanderi has run 3 trials for Cancer. Some of their research focus areas include:
Non-Hodgkin's Lymphoma
Viralkumar Bhanderi has run 2 trials for Non-Hodgkin's Lymphoma. Some of their research focus areas include:
Affiliated Hospitals
Florida Cancer Specialists
Florida Cancer Specialists - Panhandle
Clinical Trials Viralkumar Bhanderi is currently running
APL-101
for Lung Cancer
This trial is testing APL-101, a new drug, on patients with specific genetic changes in their cancer. These patients often don't respond to typical treatments. The drug aims to block a protein that helps cancer cells grow and spread.
Recruiting
1 award
Phase 2
11 criteria
Targeted Therapy
for Advanced Stage Cancer
The purpose of the study is to learn from the real world practice of prescribing targeted therapies to patients with advanced cancer whose tumor harbors a genomic variant known to be a drug target or to predict sensitivity to a drug. NOTE: Due to character limits, the arms section does NOT include all TAPUR Study relevant biomarkers. For additional information, contact TAPUR@asco.org, or if a patient, your nearest participating TAPUR site (see participating centers). \*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\* Results in publication or poster presentation format are posted as they become available for individual cohorts at www.tapur.org/news. The results may be accessed at any time. All results will be made available on clinicaltrials.gov at the end of the study. Indexing of available results on PubMed is in progress. \*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*
Recruiting
1 award
Phase 2
9 criteria
More about Viralkumar Bhanderi
Clinical Trial Related
5 years of experience running clinical trials · Led 13 trials as a Principal Investigator · 3 Active Clinical Trials
Treatments Viralkumar Bhanderi has experience with
- Rituximab
- Etrumadenant
- Futibatinib
- Abemaciclib
- Lenalidomide
- Tazemetostat
Breakdown of trials Viralkumar Bhanderi has run
Cancer
Non-Hodgkin's Lymphoma
Colorectal Cancer
Pancreatic Cancer
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Viralkumar Bhanderi specialize in?
Viralkumar Bhanderi focuses on Cancer and Non-Hodgkin's Lymphoma. In particular, much of their work with Cancer has involved Stage IV patients, or patients who are Stage III.
Is Viralkumar Bhanderi currently recruiting for clinical trials?
Yes, Viralkumar Bhanderi is currently recruiting for 3 clinical trials in Tallahassee Florida. If you're interested in participating, you should apply.
Are there any treatments that Viralkumar Bhanderi has studied deeply?
Yes, Viralkumar Bhanderi has studied treatments such as Rituximab, Etrumadenant, Futibatinib.
What is the best way to schedule an appointment with Viralkumar Bhanderi?
Apply for one of the trials that Viralkumar Bhanderi is conducting.
What is the office address of Viralkumar Bhanderi?
The office of Viralkumar Bhanderi is located at: Florida Cancer Specialists, Tallahassee, Florida 32308 United States. This is the address for their practice at the Florida Cancer Specialists.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.
Unbiased Results
We believe in providing patients with all the options.
Your Data Stays Your Data
We only share your information with the clinical trials you're trying to access.
Verified Trials Only
All of our trials are run by licensed doctors, researchers, and healthcare companies.